IL110994A - Process for preparing a history of 2-transformed-H3-imidazo [B-4,5] pyridine - Google Patents

Process for preparing a history of 2-transformed-H3-imidazo [B-4,5] pyridine

Info

Publication number
IL110994A
IL110994A IL110994A IL11099494A IL110994A IL 110994 A IL110994 A IL 110994A IL 110994 A IL110994 A IL 110994A IL 11099494 A IL11099494 A IL 11099494A IL 110994 A IL110994 A IL 110994A
Authority
IL
Israel
Prior art keywords
general formula
alkyl
aryl
groups
preparing
Prior art date
Application number
IL110994A
Other languages
English (en)
Hebrew (he)
Other versions
IL110994A0 (en
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag filed Critical Lonza Ag
Publication of IL110994A0 publication Critical patent/IL110994A0/xx
Publication of IL110994A publication Critical patent/IL110994A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL110994A 1993-09-17 1994-09-18 Process for preparing a history of 2-transformed-H3-imidazo [B-4,5] pyridine IL110994A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH281693 1993-09-17

Publications (2)

Publication Number Publication Date
IL110994A0 IL110994A0 (en) 1994-11-28
IL110994A true IL110994A (en) 1998-02-08

Family

ID=4242236

Family Applications (1)

Application Number Title Priority Date Filing Date
IL110994A IL110994A (en) 1993-09-17 1994-09-18 Process for preparing a history of 2-transformed-H3-imidazo [B-4,5] pyridine

Country Status (22)

Country Link
US (1) US5446160A (hu)
EP (1) EP0645389B1 (hu)
JP (1) JP3713724B2 (hu)
KR (1) KR950008512A (hu)
AT (1) ATE148702T1 (hu)
AU (1) AU680025B2 (hu)
BR (1) BR9403594A (hu)
CA (1) CA2131680C (hu)
CZ (1) CZ285489B6 (hu)
DE (1) DE59401760D1 (hu)
DK (1) DK0645389T3 (hu)
ES (1) ES2098089T3 (hu)
GR (1) GR3022500T3 (hu)
HU (1) HU218488B (hu)
IL (1) IL110994A (hu)
PL (1) PL305067A1 (hu)
RU (1) RU94033473A (hu)
SI (1) SI0645389T1 (hu)
SK (1) SK111494A3 (hu)
TR (1) TR27788A (hu)
TW (1) TW410225B (hu)
ZA (1) ZA947189B (hu)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312853D0 (en) 1993-06-22 1993-08-04 Euro Celtique Sa Chemical compounds
US5922751A (en) 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
US5591776A (en) 1994-06-24 1997-01-07 Euro-Celtique, S.A. Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
US6075016A (en) 1996-04-10 2000-06-13 Euro-Celtique S.A. 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
IL133800A0 (en) 1997-07-03 2001-04-30 Du Pont Pharm Co Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
US6124463A (en) * 1998-07-02 2000-09-26 Dupont Pharmaceuticals Benzimidazoles as corticotropin release factor antagonists
US6365589B1 (en) 1998-07-02 2002-04-02 Bristol-Myers Squibb Pharma Company Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
EP1244666A1 (en) * 1999-12-17 2002-10-02 Bristol-Myers Squibb Pharma Company Imidazopyrimidinyl and imidazopyridinyl derivatives
AU2004266658A1 (en) 2003-08-12 2005-03-03 3M Innovative Properties Company Hydroxylamine substituted imidazo-containing compounds
KR101106812B1 (ko) 2003-08-27 2012-01-19 쓰리엠 이노베이티브 프로퍼티즈 컴파니 아릴옥시 및 아릴알킬렌옥시 치환된 이미다조퀴놀린
EP1660026A4 (en) 2003-09-05 2008-07-16 3M Innovative Properties Co TREATMENT FOR CD5 + B CELL LYMPHOMA
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
JP5043435B2 (ja) 2003-10-03 2012-10-10 スリーエム イノベイティブ プロパティズ カンパニー アルコキシ置換イミダゾキノリン
EP1685129A4 (en) 2003-11-14 2008-10-22 3M Innovative Properties Co OXIMSUBSTITUTED IMIDAZORING CONNECTIONS
JP2007511535A (ja) 2003-11-14 2007-05-10 スリーエム イノベイティブ プロパティズ カンパニー ヒドロキシルアミン置換イミダゾ環化合物
WO2005051317A2 (en) 2003-11-25 2005-06-09 3M Innovative Properties Company Substituted imidazo ring systems and methods
US8802853B2 (en) 2003-12-29 2014-08-12 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
JP2007517044A (ja) 2003-12-30 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー イミダゾキノリニル、イミダゾピリジニル、およびイミダゾナフチリジニルスルホンアミド
WO2005094531A2 (en) 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
US7897609B2 (en) 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
WO2006065280A2 (en) 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
WO2006083440A2 (en) 2004-12-30 2006-08-10 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
US7943609B2 (en) 2004-12-30 2011-05-17 3M Innovative Proprerties Company Chiral fused [1,2]imidazo[4,5-C] ring compounds
CA2597092A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune reponse modifiers
EP1846405A2 (en) 2005-02-11 2007-10-24 3M Innovative Properties Company Oxime and hydroxylamine substituted imidazo 4,5-c ring compounds and methods
WO2006121528A2 (en) * 2005-04-01 2006-11-16 Coley Pharmaceutical Group, Inc. Ring closing and related methods and intermediates
JP2008535832A (ja) 2005-04-01 2008-09-04 コーリー ファーマシューティカル グループ,インコーポレイテッド ピラゾロピリジン−1,4−ジアミン、およびそのアナログ
CA2602590A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
KR20080048551A (ko) * 2005-09-23 2008-06-02 콜레이 파마시티컬 그룹, 인코포레이티드 1H-이미다조[4,5-c]피리딘 및 그의 유사체의 제조법
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
US20080139608A1 (en) * 2006-12-06 2008-06-12 Universiteit Leiden 2,6,8, Trisubstituted 1-deazapurines and their different uses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3324115A1 (de) * 1983-07-05 1985-01-17 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel
FR2643903A1 (fr) * 1989-03-03 1990-09-07 Union Pharma Scient Appl Nouveaux derives de benzimidazole, leurs procedes de preparation, intermediaires de synthese, compositions pharmaceutiques les contenant, utiles notamment pour le traitement des maladies cardiovasculaires, et des ulceres duodenaux
US5223499A (en) * 1989-05-30 1993-06-29 Merck & Co., Inc. 6-amino substituted imidazo[4,5-bipyridines as angiotensin II antagonists
US5240938A (en) * 1991-02-13 1993-08-31 Merck & Co., Inc. Angiotensin II antagonists incorporating a substituted pyridoimidazolyl ring
US5066654A (en) * 1990-10-22 1991-11-19 A. H. Robins Company, Incorporated 2-aryl-3-heterocyclicmethyl-3H-imidazo[4,5-b]pyridines as anxiolytics and anticonvulsants
US5128327A (en) * 1991-03-25 1992-07-07 Merck & Co., Inc. Angiotensin II antagonists incorporating a nitrogen containing six membered ring heterocycle

Also Published As

Publication number Publication date
JPH07179465A (ja) 1995-07-18
SK111494A3 (en) 1995-06-07
DE59401760D1 (de) 1997-03-20
GR3022500T3 (en) 1997-05-31
EP0645389A1 (de) 1995-03-29
EP0645389B1 (de) 1997-02-05
BR9403594A (pt) 1995-05-16
RU94033473A (ru) 1996-08-10
KR950008512A (ko) 1995-04-17
HU218488B (hu) 2000-09-28
AU7305894A (en) 1995-03-30
TW410225B (en) 2000-11-01
ZA947189B (en) 1995-05-12
ATE148702T1 (de) 1997-02-15
SI0645389T1 (en) 1997-10-31
CA2131680C (en) 2006-11-07
JP3713724B2 (ja) 2005-11-09
DK0645389T3 (da) 1997-03-10
TR27788A (tr) 1995-08-29
CZ226694A3 (en) 1995-04-12
PL305067A1 (en) 1995-03-20
HUT68250A (en) 1995-06-28
HU9402662D0 (en) 1994-11-28
CA2131680A1 (en) 1995-03-18
CZ285489B6 (cs) 1999-08-11
ES2098089T3 (es) 1997-04-16
AU680025B2 (en) 1997-07-17
US5446160A (en) 1995-08-29
IL110994A0 (en) 1994-11-28

Similar Documents

Publication Publication Date Title
US5446160A (en) Process for preparing imidazopyridine derivatives
EP0705262A1 (en) Process for asymmetric total synthesis of camptothecin
US5446159A (en) Process for preparing imidazopyridine derivatives
US4002755A (en) Triazoloquinazolines
EP3515893B1 (en) Process for preparing 3-fluoroalkyl-5-pyrazolecarboxylates and 3-fluoroalkyl-5-pyrazolecarboxylic acids
US5569661A (en) Process for the production of b-carbolines
EP0514917B1 (en) Process for and 2-(cyanoimino)-quinazoline derivatives useful as intermediates in the preparation of 6,7-di-(chloro)-1,5-di(hydro)-imidazo-[2,1-b]quinazolin-2[3H]-one and process for preparing the 2-(cyanoimino)-quinazoline derivatives
US2963478A (en) 4, 7-diamino-nu-aralkyl-2-aryl-6-pteridinecarboxamides
US3937713A (en) Process for the preparation of s-triazolo[3,4-b]benzothiazoles
CA2087098A1 (en) Hetero-aryloxy-.beta.-carbolines, their preparation and their use in medicamens
US4082762A (en) 4-(2-halophenyl)-1,2,4-triazole-3-thiol compounds
YOSHIDA et al. Synthesis of Condensed Quinoxalines. VI. Synthesis of 1H-Pyrazolo [3, 4-b] quinoxaline N-Oxides and Related Compounds
US6066736A (en) Process for preparing alkoxypyrazine derivatives
US5466800A (en) Process for the preparation of 2,5-disubstituted pyridines
EP0033214A2 (en) Process for preparing therapeutically active triazoles
KAKEHI et al. Preparation of New Nitrogen-Bridged Heterocycles. XXIV.: Syntheses and Reactions of Pyrazolo [1, 5-a] pyridine-2-thiols.(2)
HU194176B (en) Process for production of derivatives of new 7-phormildekahydridinoline
PL171318B1 (en) Method of obtaining benzo[b]naphtyridines
US4134914A (en) 1-Acyl-4-substituted phenyl thiosemicarbazides
Hassanien et al. Aminomethylene ketones and enamines in heterocyclic synthesis: synthesis of functionally substituted pyridine, pyrazole, fused pyrimidine and fused [1, 5] diazocine derivatives
KR0151818B1 (ko) 피리딜 이미다졸 유도체의 제조방법
JPS61200978A (ja) 3−置換アミノ−1,3−チアゾリジン−2,4−ジオン誘導体及びその製造法
筧昭一 et al. Preparation of new nitrogen-bridged heterocycles. XXIV. Syntheses and reactions of pyrazolo (1, 5-a) pyridine-2-thiols.(2).
Kuge et al. A Facile Synthesis of 5-Phenylimidazo-[4, 5-c]-[1, 8] naphthyridin-4 (5 H)-one
Dabaeva et al. Derivatives of Condensed Pyridopyrimidines. 3. Synthesis of Condensed Imidazo [4, 5-b] pyridine and also 4-Oxo-and 2, 4-Dioxopyrido [2, 3-d] pyrimidines

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees